Copyright
©The Author(s) 2020.
World J Gastrointest Surg. Dec 27, 2020; 12(12): 520-533
Published online Dec 27, 2020. doi: 10.4240/wjgs.v12.i12.520
Published online Dec 27, 2020. doi: 10.4240/wjgs.v12.i12.520
Figure 1 Survival of patients according to alpha-fetoprotein and gamma glutamyl transpeptidase alone.
A: Overall and disease-free survival of 50 patients; B: Overall and disease-free survival according to alpha-fetoprotein (AFP) ≤ 200 ng/mL vs AFP > 200 ng/mL; C: Overall and disease-free survival according to gamma glutamyl transpeptidase (GGT) ≤ 104 IU/L vs GGT > 104 IU/L.
Figure 2 Survival of patients according to alpha-fetoprotein and gamma glutamyl transpeptidase combinations.
A: Overall and disease-free survival according to alpha-fetoprotein (AFP) and gamma glutamyl transpeptidase (GGT) combinations (low AFP + low GGT, high AFP + low GGT, low AFP + high GGT and high AFP + high GGT); B: Overall and disease-free survival according to low AFP + low GGT vs all other AFP + GGT combinations.
Figure 3 Survival of patients according to maximum dominant tumor diameter size and alpha-fetoprotein-gamma glutamyl transpeptidase combinations.
A: Overall survival in the maximum tumor diameter band 6-10 cm according to low alpha-fetoprotein (AFP) + low gamma glutamyl transpeptidase (GGT) vs all other combinations; B: Overall survival in the maximum tumor diameter band > 10 cm according to low AFP + low GGT vs all other AFP + GGT combinations.
- Citation: Ince V, Carr BI, Bag HG, Ersan V, Usta S, Koc C, Gonultas F, Sarici BK, Karakas S, Kutluturk K, Baskiran A, Yilmaz S. Liver transplant for large hepatocellular carcinoma in Malatya: The role of gamma glutamyl transferase and alpha-fetoprotein, a retrospective cohort study. World J Gastrointest Surg 2020; 12(12): 520-533
- URL: https://www.wjgnet.com/1948-9366/full/v12/i12/520.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v12.i12.520